Skip to content
Personal information

Foreign Supplier Verification Program inspection of California import company leads to FDA warning

Foreign Supplier Verification Program inspection of California import company leads to FDA warning
Published:

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months after they are sent. Business owners have 15 days to respond to FDA warning letters. Warning letters often are not issued until a company has been given months to years to correct problems.


Del Valle Import & Export 3, Inc. DBA El Progreso Imports
Vernon, CA

An import company in California is on notice from the FDA for not having FSVPs for a number of imported food products.

In a July 18, 2023, warning letter, the FDA described a Feb. 22-28, 2022, Foreign Supplier Verification Program (FSVP) inspection of Del Valle Import & Export 3, Inc. dba El Progreso Imports in Vernon, CA.

The FDA also conducted inspections from Sept. 7-13, 2022, Feb. 4 through March 5, 2021, and Feb. 6-12, 2019. These inspections were conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug and Cosmetic Act and the FSVP implementing regulation.

The FDA’s most recent inspection revealed that the firm was not in compliance with FSVP regulations and resulted in the issuance of an FDA Form 483a. The significant violations are as follows:

The full warning letter can be viewed here.

(To sign up for a free subscription to Food Safety News, click here.)

News Desk

News Desk

The News Desk team at Food Safety News covers breaking developments, regulatory updates, recalls, and key topics shaping food safety today. These articles are produced collaboratively by our editorial staff.

All articles

More in Enforcement

See all

More from News Desk

See all

Sponsored Content

Your Support Protects Public Health

Food Safety News is nonprofit and reader-funded. Your gift ensures critical coverage of outbreaks, recalls, and regulations remains free for everyone.